Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

481 ARTÍCULOS , VIENDO DEL 106 AL 120

An integrative machine-learning meta-analysis of high-throughput omics data identifies age-specific hallmarks of Alzheimer's disease

Shokhirev MN, Johnson AA.

Ageing Res Rev. 2022 Nov;81:101721. doi: 10.1016/j.arr.2022.101721. Epub 2022 Aug 25.

Opportunities and challenges in delivering biologics for Alzheimer's disease by low-intensity ultrasound

Chen L, Cruz E, Oikari LE, Padmanabhan P, Song J, Götz J.

Adv Drug Deliv Rev. 2022 Oct;189:114517. doi: 10.1016/j.addr.2022.114517. Epub 2022 Aug 25.

Incidence of Amyloid-Related Imaging Abnormalities in Patients With Alzheimer Disease Treated With Anti-β-Amyloid Immunotherapy: A Meta-analysis

Jeong SY, Suh CH, Shim WH, Lim JS, Lee JH, Kim SJ.

Neurology. 2022 Nov 8;99(19):e2092-e2101. doi: 10.1212/WNL.0000000000201019. Epub 2022 Aug 29.

Preemptive Diagnosis of Alzheimer's Disease in the Eastern Province of Saudi Arabia Using Computational Intelligence Techniques

Olatunji SO, Alansari A, Alkhorasani H, Alsubaii M, Sakloua R, Alzahrani R, Alsaleem Y, Alassaf R, Farooqui M, Basheer Ahmed MI, Alhiyafi J.

Comput Intell Neurosci. 2022 Aug 23;2022:5476714. doi: 10.1155/2022/5476714. eCollection 2022.

[Recognizing Alzheimer's disease in daily practice]

Witkowska-Płusa U, Dubielis A, Płusa T.

Pol Merkur Lekarski. 2022 Aug 23;50(298):253-256.

Cognitive Resilience in Brain Health and Dementia Research

Joshi MS, Galvin JE.

J Alzheimers Dis. 2022;90(2):461-473. doi: 10.3233/JAD-220755.

A Pilot Study of Whole-Brain Low-Intensity Pulsed Ultrasound Therapy for Early Stage of Alzheimer's Disease (LIPUS-AD): A Randomized, Double-Blind, Placebo-Controlled Trial

Shimokawa H, Shindo T, Ishiki A, Tomita N, Ichijyo S, Watanabe T, Nakata T, Eguchi K, Kikuchi Y, Shiroto T, Takahashi J, Yasuda S, Arai H.

Tohoku J Exp Med. 2022 Oct 25;258(3):167-175. doi: 10.1620/tjem.2022.J078. Epub 2022 Sep 15.

Sarcopenia screening in elderly with Alzheimer's disease: performances of the SARC-F-3 and MSRA-5 questionnaires

Bramato G, Barone R, Barulli MR, Zecca C, Tortelli R, Filardi M, Logroscino G.

BMC Geriatr. 2022 Sep 17;22(1):761. doi: 10.1186/s12877-022-03441-5.

Effects of Simvastatin on Plasma Amyloid-β Transport in Patients with Hyperlipidemia: A 12-Week Randomized, Double-Blind, Placebo-Controlled Trial

Wei S, Dang L, Gao F, Wang J, Wang J, Qu Q.

J Alzheimers Dis. 2022;90(1):349-362. doi: 10.3233/JAD-220240.

Evaluating the Safety and Efficacy of Crenezumab vs Placebo in Adults With Early Alzheimer Disease: Two Phase 3 Randomized Placebo-Controlled Trials

Ostrowitzki S, Bittner T, Sink KM, Mackey H, Rabe C, Honig LS, Cassetta E, Woodward M, Boada M, van Dyck CH, Grimmer T, Selkoe DJ, Schneider A, Blondeau K, Hu N, Quartino A, Clayton D, Dolton M, Dang Y, Ostaszewski B, Sanabria-Bohórquez SM, Rabbia M, Toth B, Eichenlaub U, Smith J, Honigberg LA, Doody RS.

JAMA Neurol. 2022 Nov 1;79(11):1113-1121. doi: 10.1001/jamaneurol.2022.2909.

Potential of fluorescent nanoprobe in diagnosis and treatment of Alzheimer's disease

Lin J, Li H, Guo J, Xu Y, Li H, Yan J, Wang Y, Chen H, Yuan Z.

Nanomedicine (Lond). 2022 Jul;17(17):1191-1211. doi: 10.2217/nnm-2022-0022. Epub 2022 Sep 26.

Global cognitive effects of second-generation antidepressants in patients with Alzheimer's disease: A systematic review and meta-analysis of randomized controlled trials

Qin M, Wu J, Zhou Q, Liang Z, Su Y.

J Psychiatr Res. 2022 Nov;155:371-379. doi: 10.1016/j.jpsychires.2022.09.039. Epub 2022 Sep 25.

Photobiomodulation for Hypertension and Alzheimer's Disease

Valverde A, Mitrofanis J.

J Alzheimers Dis. 2022;90(3):1045-1055. doi: 10.3233/JAD-220632.

Recent advances in small molecular near-infrared fluorescence probes for a targeted diagnosis of the Alzheimer disease

Liu Y, Zhuang D, Wang J, Huang H, Li R, Wu C, Deng Y, Hu G, Guo B.

Analyst. 2022 Oct 24;147(21):4701-4723. doi: 10.1039/d2an01327d.

A systematic review of the validity of non-invasive sleep-measuring devices in mid-to-late life adults: Future utility for Alzheimer's disease research

Green SF, Frame T, Banerjee LV, Gimson A, Blackman J, Morrison H, Lloyd K, Rudd S, Frederick Fotherby WG, Bartsch U, Purcell S, Jones M, Coulthard L.

Sleep Med Rev. 2022 Oct;65:101665. doi: 10.1016/j.smrv.2022.101665. Epub 2022 Aug 21.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias